Global Pharmaceutical Sciences NCF-LC, GPRD, Abbott Laboratories, R4P7, 100 Abbott Park Road, Abbott Park, Illinois 60064, USA.
AAPS J. 2012 Dec;14(4):703-13. doi: 10.1208/s12248-012-9389-7. Epub 2012 Jul 14.
With the increasing number of poorly water-soluble compounds in contemporary drug discovery pipelines, the concept of supersaturation as an effective formulation approach for enhancing bioavailability is gaining momentum. This is intended to design the formulation to yield significantly high intraluminal concentrations of the drug than the thermodynamic equilibrium solubility through achieving supersaturation and thus to enhance the intestinal absorption. The major challenges faced by scientists developing supersaturatable formulations include controlling the rate and degree of supersaturation with the application of polymeric precipitation inhibitor and maintenance of post-administration supersaturation. This review is intended to cover publications on this topic since April 2009. Scientific publications associated with characterization of supersaturatable systems and related preclinical and clinical pharmacokinetics (PK) studies are reviewed. Specifically, this review will address issues related to assessing the performance of supersaturatable systems including: (1) Diversified approaches for developing supersaturatable formulations, (2) meaningful in vitro test methods to evaluate supersaturatable formulations, and (3) in vivo PK study cases which have demonstrated direct relevance between the supersaturation state and the exposure observed in animal models and human subjects.
随着当代药物发现管道中越来越多的水溶性差的化合物,将过饱和状态作为提高生物利用度的有效制剂方法的概念正在兴起。其目的是通过实现过饱和来设计制剂,从而产生比热力学平衡溶解度显著更高的腔内药物浓度,进而增强肠道吸收。开发超饱和制剂的科学家面临的主要挑战包括通过应用聚合物沉淀抑制剂控制过饱和度的速度和程度,并保持给药后的过饱和状态。本综述旨在涵盖自 2009 年 4 月以来关于该主题的出版物。综述了与超饱和系统的特性以及相关的临床前和临床药代动力学 (PK) 研究相关的科学出版物。具体而言,本综述将解决与评估超饱和系统的性能相关的问题,包括:(1) 开发超饱和制剂的多样化方法,(2) 评估超饱和制剂的有意义的体外测试方法,以及 (3) 在 PK 研究案例中,超饱和状态与动物模型和人体中观察到的暴露之间存在直接相关性。